October 29, 2024
Abu Dhabi, UAE — New evidence supports the use of direct oral anticoagulants (DOACs) in the treatment of cerebral venous thrombosis (CVT) based on findings from […]
October 29, 2024
SAN ANTONIO — The upcoming Obesity Week meeting will feature new clinical trial data for glucagon-like peptide 1 receptor agonist (GLP-1 RA) drugs, along with deep […]
October 29, 2024
The European Alliance of Associations for Rheumatology (EULAR) is launching a new open-access journal — EULAR Rheumatology Open — in January 2025. The announcement is one of […]
October 29, 2024
Despite some recent progress in compensation equity, women in medicine continue to be paid significantly lower salaries than men. According to the Female Compensation Report 2024 […]
October 29, 2024
Identifying populations at an increased risk for HIV and preventing outbreaks remain a challenge, but researchers are using tracking technology to find these at-risk individuals and […]
October 29, 2024
A group of researchers from the University of Pennsylvania, Philadelphia, has developed a messenger RNA (mRNA) vaccine, delivered via lipid nanoparticles (LNPs) — the same type […]
October 29, 2024
Telemedicine has had a profound impact on the way care is delivered to patients. Its many advantages have led to its increased use, not to mention […]
October 29, 2024
PHILADELPHIA — The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with a significant decrease in the risk for early-onset colorectal cancer (EO-CRC) […]
October 29, 2024
SAN DIEGO — The investigational drug pegcetacoplan, a C3/C3b inhibitor, showed significant benefits in the treatment of patients with C3 glomerulopathy or primary immune complex–mediated membranoproliferative […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434
Next page